Conclusion
Conformational analysis by NMR spectroscopy and molecular modeling revealed a left-handed PPII helix-like structure for Trp2-Tat(1–9) (cis and trans) and an even more flexible structure for TXA2-R(1–9).
PPII helices form a well-defined structural class comparable with the other structures defined in proteins and are characterized by exposed, mobile structures with 4–8 residues, mostly found on the protein surface. Polyproline II helices are mainly identified by their torsion angles of φ∼−75° and Ψ∼145−. They do not form regular interchain hydrogen bonds, but are hydrogen bonded with water molecules. PPII helices have a strong preference for the amino acid proline, although it is not necessarily present. These features were also reported for the parent peptide Tat(1–9)4 as well as for the well known DP IV substrates neuropeptide Y and pancreatic polypeptide5 suggesting that PPII-like helical structures represent a favored structural class for the interaction with DP IV.
Thus, the considerable enhancement of the inhibition capacity of both Trp2-Tat(1–9) and TXA2-R(1–9) compared to the moderate inhibitor Tat(1–9)2, Ki=2.68±0.01 10−4 M, can only be due to tryptophan in the second position suggesting that its side chain is favored to exhibit attractive hydrophobic interactions with DP IV compared with aspartic acid.
On the other hand, we could show recently that Tat(1–9) and its analogues as well as TXA2-R(1–9) inhibit DP IV according to different inhibition mechanisms (Lorey et al., manuscript submitted). One possible explanation for these findings might be enzyme-ligand interactions relying on multiple weak binding sites as described for PPII helices5 rather than specific lock and key binding. Certainly, only an X-ray structure of DP IV would help to understand the interaction of DP IV with inhibitors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wrenger, S., Reinhold, D., Hoffmann, T., Kraft., M., Frank, R., Faust, J., Neubert, K., and Ansorge, S., 1996, The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells. FEBS Lett. 383: 145–149.
Wrenger, S., Faust, J., Mrestani-Klaus, C., Fengler, A., Stöckel-Maschek, A., Lorey, S., Kähne, T., Brandt, W., Neubert, K., Ansorge, S., and Reinhold, D., 2000, Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor. J. Biol. Chem. 275: 22180–22186.
Mrestani-Klaus, C., Fengler, A., Faust, J., Brandt, W., Wrenger, S., Reinhold, D., Ansorge, S., and Neubert, K., 2001, Conformational study of a tryptophan containing Tat(1–9) analogue as potent inhibitor of dipeptidyl peptidase IV. In Peptides 2000 (J. Martinez and J. A. Fehrentz, eds.), Editions EDK, Paris, pp. 511–512.
Kanyalkar, M., Srivastava, S., and Coutinho, E., 2001, Conformation of N-terminal HIV-1 Tat (fragment 1–9) peptide by NMR and MD simulations. J. Peptide Sci. 7: 579–587.
Williamson, M. P., 1994, The structure and function of proline-rich regions in proteins. Biochem. J. 297: 249–260.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Mrestani-Klaus, C. et al. (2004). New Results on the Conformations of Potent DP IV (CD26) Inhibitors bearing the N-terminal MWP Structural Motif. In: Back, N., Cohen, I.R., Kritchevsky, D., Lajtha, A., Paoletti, R. (eds) Dipeptidyl Aminopeptidases in Health and Disease. Advances in Experimental Medicine and Biology, vol 524. Springer, Boston, MA. https://doi.org/10.1007/0-306-47920-6_7
Download citation
DOI: https://doi.org/10.1007/0-306-47920-6_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47717-1
Online ISBN: 978-0-306-47920-5
eBook Packages: Springer Book Archive